Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202305
Company: SANDOZ

Products on ANDA 202305

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
AZELASTINE HYDROCHLORIDE	AZELASTINE HYDROCHLORIDE	0.05%	SOLUTION/DROPS;OPHTHALMIC	Prescription	AT	No	Yes

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 202305

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
05/31/2012	ORIG-1	Approval				Label is not available on this site.

Therapeutic Equivalents for ANDA 202305

AZELASTINE HYDROCHLORIDE

SOLUTION/DROPS;OPHTHALMIC; 0.05%
TE Code = AT

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
AZELASTINE HYDROCHLORIDE	AZELASTINE HYDROCHLORIDE	0.05%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	209620	ALEMBIC
AZELASTINE HYDROCHLORIDE	AZELASTINE HYDROCHLORIDE	0.05%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	078621	APOTEX
AZELASTINE HYDROCHLORIDE	AZELASTINE HYDROCHLORIDE	0.05%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	210092	GLAND
AZELASTINE HYDROCHLORIDE	AZELASTINE HYDROCHLORIDE	0.05%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	202305	SANDOZ
AZELASTINE HYDROCHLORIDE	AZELASTINE HYDROCHLORIDE	0.05%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	207411	SOMERSET THERAPS LLC